2015The Journal of Steroid Biochemistry and Molecular BiologyRequires access

Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme

André Otávio Peres Protzek, Luiz Fernando de Rezende, José Maria Costa-Júnior, Sandra Mara Ferreira, Ana Paula Gameiro Cappelli, Flávia M. Paula, Jane Cristina de Souza, Mirian Ayumi Kurauti, Everardo M. Carneiro, Alex Rafacho, Antônio C. Boschero

Open publisher page 51 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 51 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hyperinsulinemia, Endocrinology, Internal medicine, Insulin, Glucocorticoid, Dexamethasone, Insulin resistance, Hyperinsulinism

Related papers

Back to paper searchBrowse research topicsOriginal source
Hyperinsulinemia caused by dexamethasone treatment is associated with reduced insulin clearance and lower hepatic activity of insulin-degrading enzyme — Research Paper | ScholarLens